Death with tuberculosis in California, 1994-2008

Open Forum Infectious Diseases

Volumn 1, Issue 3, 2014, Pages

  Pascopella, Lisa ^a   Barry, Pennan M ^a   Flood, Jennifer ^a   DeRiemer, Kathryn ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Death; Public health; Risk factors; Trends; Tuberculosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SURVEILLANCE; FEMALE; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PUBLIC HEALTH; RETROSPECTIVE STUDY; RISK FACTOR; SUBSTANCE USE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOUS MENINGITIS; TUBERCULOUS PERITONITIS; UNITED STATES;

EID: 84978327809     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu090     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention (CDC). Reported tuberculosis in the United States, 2012. Atlanta, GA: Department of Health and Human Services, 2013.
2. Sterling TR, Zhao Z, Khan A, et al. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis. 2006;10:542-9.
3. Isanaka S, Mugusi F, Urassa W, et al. Iron deficiency and anemia predict mortality in patients with tuberculosis. J Nutr. 2012;142: 350-7.
4. Centers for Disease Control and Prevention (CDC). Trends in tuberculosis-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:181-5.
5. Curtis AB, McCray E, McKenna M, et al. Completeness and timeliness of tuberculosis case reporting. A multistate study. Am J Prev Med. 2001;20:108-12.
6. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-51.
7. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: John Wiley and Sons, Inc, 2000.
8. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340-9.
9. Jung RS, Bennion JR, Sorvillo F, et al. Trends in tuberculosis mortality in the United States, 1990-2006: a population-based case-control study. Public Health Rep. 2010;125:389-97.
10. Centers for Disease Control and Prevention (CDC). Quickstats: age-adjusted death rates from tuberculosis, by race and sex-National Vital Statistics System, United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013;62:865.
11. Barnes RF, Moore ML, Garfein RS, et al. Trends in mortality of tuberculosis patients in the United States: the long-term perspective. Ann Epidemiol. 2011;21:791-5.
12. Metcalfe JZ, Porco TC, Westenhouse J, et al. Tuberculosis and HIV coinfection, California, USA, 1993-2008. Emerg Infect Dis. 2013;19: 400-6.
13. Marcy O, Laureillard D, Madec Y, et al. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clin Infect Dis. 2014;59:435-45.
14. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49:1-51.
15. Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58:1-207.
16. Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC. 2014;9:1-15.
17. Wobeser W, Yuan L, Naus M. Outcome of pulmonary tuberculosis treatment in the tertiary care setting-Toronto 1992/93. Tuberculosis Treatment Completion Study Group [see comments]. CMAJ. 1999; 160:789-94.
18. Skogberg K, Ruutu P, Tukiainen P, et al. Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis. Clin Infect Dis. 1993;17:1012-7.
19. Horne DJ, Hubbard R, Narita M, et al. Factors associated with mortality in patients with tuberculosis. BMC Infect Dis. 2010;10:258.
20. California Department of Public Health, California Tuberculosis Control Branch, California Tuberculosis Controllers Association. Responsibilities of public health departments to control tuberculosis. http://www.ctca.org/fileLibrary/file_494.pdf. Accessed February 27, 2014.
21. American Thoracic Society, Centers for Disease and Prevention, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52:1-77.
22. Association of State and Territorial Health Officials. Budget cuts continue to affect the health of Americans. http://www.astho.org/budget-cutsdec-2012/. Accessed February 27, 2014.
23. National Association of County and City Health Officials. Local health department job losses and program cuts: findings from the 2013 Profile Study. http://naccho.org/topics/infrastructure/lhdbudget/upload/survey-findings-brief-8-13-13-4.pdf. Accessed February 27, 2014.
24. Porco TC, Oh P, Flood JM. Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006 Clin Infect Dis. 2013;56:761-9.
25. California Department of Public Health. Information for physicians regarding directly observed therapy (DOT) for active tuberculosis (TB). http://www.cdph.ca.gov/programs/tb/Documents/TBCB-PMD-DOT. pdf. Accessed February 27, 2014.
26. Beavers S, Flood J, Weinfurter P, et al. Tuberculosis mortality in the United States: how can it be prevented? In: American Thoracic Society International Conference. San Francisco, California; 2012.